Share page on LinkedIn

Early Phase

ICON specialises in the strategy and delivery of early phase clinical development for informed, timely decision making.

We incorporate scientific excellence and product develop strategy with expertise in early phase clinical research, bioanalytical, PK/PD modeling & simulation, and the full range of supporting services.

Our multi-disciplinary experts have the experience to address the most demanding drug development challenges to:

Complete projects on time

Cross-functional teams for innovative RWE strategies and late phase research

Deliver within targeted budget

Services built upon the industry's most respected health outcomes organisations

Ensure quality that withstands vigorous scrutiny

Resources and expertise to achieve product authorisation, accelerate market access, and drive product adoption

Early Phase Social Media Posts